Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents?

SIMPLE SUMMARY: Anticancer agents causing DNA damage are widely used in the treatment of ovarian cancer; however, predictive biomarkers capable of optimizing the selection of patients with the best likelihood of a good response have not been defined yet. The newly discovered protein Schlafen 11 was...

Descripción completa

Detalles Bibliográficos
Autores principales: Bednarikova, Marketa, Hausnerova, Jitka, Ehrlichova, Lucie, Matulova, Kvetoslava, Gazarkova, Eliska, Minar, Lubos, Weinberger, Vit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139752/
https://www.ncbi.nlm.nih.gov/pubmed/35625957
http://dx.doi.org/10.3390/cancers14102353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139752/
https://www.ncbi.nlm.nih.gov/pubmed/35625957
http://dx.doi.org/10.3390/cancers14102353

Ejemplares similares